Hls Pharmacies, Inc.
HLS Pharmacies, Inc., headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in innovative healthcare solutions. Founded in 2001, the company has established itself as a trusted provider of pharmacy services, primarily focusing on medication management and specialty pharmacy solutions. With a strong operational presence across various regions in the US, HLS Pharmacies is dedicated to enhancing patient care through personalised services and advanced technology. The company’s core offerings include comprehensive medication therapy management, specialty drug distribution, and patient education, all designed to optimise health outcomes. HLS Pharmacies is recognised for its commitment to quality and customer service, positioning itself as a leader in the pharmacy sector. With a focus on continuous improvement and patient-centric care, HLS Pharmacies continues to achieve significant milestones in the healthcare landscape.
DitchCarbon Score
How does Hls Pharmacies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hls Pharmacies, Inc.'s score of 26 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hls Pharmacies, Inc.'s reported carbon emissions
In 2023, HLS Pharmacies, Inc. reported total carbon emissions of approximately 898,480 kg CO2e. This figure includes 98,480 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 800,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Notably, there were no reported Scope 3 emissions, which typically encompass all other indirect emissions that occur in a company’s value chain. Despite the significant emissions reported, HLS Pharmacies has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or science-based targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, HLS Pharmacies' commitment to addressing climate change will be crucial for aligning with industry standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 98,480 |
| Scope 2 | 800,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hls Pharmacies, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
